Somatostatin analog treatment of a cervical thoracic duct fistula

Authors:
Publisher website
Google Scholar
Abstract
Background Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the use of this therapy in cases arising from neck dissection. Methods We report a 16‐year‐old girl with recurrent papillary thyroid cancer who had a persistent lymphatic‐cutaneous fistula develop after repeat modified left neck dissection. Despite conservative management, drainage persisted for 2 months. A regimen was begun that included TPN and injections of a somatostatin analog. Results Treatment with a somatostatin analog resulted in an immediate attenuation of drainage and subsequent closure of the fistula after 16 days of treatment. Conclusion The use of somatostatin analog can increase the success of conservative management of thoracic duct fistulae. © 2002 Wiley Periodicals, Inc. Head Neck 24: 810–813, 2002

This publication has 16 references indexed in Scilit: